Tobacco Use Cessation Devices

Devices or delivery systems used to aid in ending a TOBACCO habit.

Also Known As:

Nicotine Delivery Devices; Nicotine Inhalant; Nicotine Lozenge; Nicotine Lozenges; Nicotine Nasal Spray; Nicotine Patch; Nicotine Polacrilex; Nicotine Replacement Products; Nicotine Transdermal Patch; Smoking Cessation Products; Delivery Device, Nicotine; Delivery Devices, Nicotine; Device, Nicotine Delivery; Devices, Nicotine Delivery; Inhalant, Nicotine; Inhalants, Nicotine; Lozenge, Nicotine; Lozenges, Nicotine; Nasal Spray, Nicotine; Nasal Sprays, Nicotine; Nicotine Delivery Device; Nicotine Inhalants; Nicotine Nasal Sprays; Nicotine Replacement Product; Patch, Nicotine; Patch, Nicotine Transdermal; Polacrilex, Nicotine; Product, Nicotine Replacement; Product, Smoking Cessation; Products, Nicotine Replacement; Products, Smoking Cessation; Replacement Product, Nicotine; Replacement Products, Nicotine; Smoking Cessation Product; Spray, Nicotine Nasal; Sprays, Nicotine Nasal; Transdermal Patch, Nicotine; Tobacco Use Cessation Products

Networked: 278 relevant articles (37 outcomes, 74 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Tobacco Use Cessation Devices: 278
  - Nicotine Chewing Gum: 30

Experts

1.	Schroeder, Darrell R: 10 articles (03/2016 - 09/2002)
2.	Ebbert, Jon O: 8 articles (03/2016 - 09/2002)
3.	Croghan, Ivana T: 8 articles (12/2013 - 01/2003)
4.	Hurt, Richard D: 7 articles (12/2013 - 09/2002)
5.	Lerman, Caryn: 6 articles (01/2021 - 03/2004)
6.	Evins, A Eden: 5 articles (03/2019 - 08/2007)
7.	Hatsukami, Dorothy K: 5 articles (01/2019 - 06/2003)
8.	Covey, Lirio S: 5 articles (12/2015 - 07/2010)
9.	Hu, Mei-Chen: 5 articles (12/2015 - 07/2010)
10.	Schnoll, Robert A: 4 articles (01/2020 - 05/2004)

Related Diseases

1.	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/01/2014 - "The combination of VLNC cigarettes and nicotine patch was more effective in reducing use of VLNC cigarettes and withdrawal symptoms among males than females, whereas females were equally responsive to VLNC cigarettes with and without the nicotine patch. " 02/01/2007 - "Few adverse events attributable to the nicotine lozenge occurred, and the lozenge was perceived as helpful in assisting subjects quit ST. The use of the 4-mg nicotine lozenge appears promising for the clinical treatment of withdrawal symptoms and craving associated with tobacco abstinence in ST users. " 04/01/2003 - "Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence." 07/18/1994 - "The nicotine patch reduced the severity of some withdrawal symptoms. " 07/18/1994 - "To evaluate the efficacy of the transdermal nicotine patch as an aid to smoking cessation when used as an adjunct to a cognitive-behavioural group intervention and to assess the effectiveness of the patch in ameliorating withdrawal symptoms. "
2.	Tobacco Use Disorder (Nicotine Dependence) 01/01/2005 - "The effect of active NRT treatment did not differ significantly by smoking rate or nicotine dependence, with the exception that the nicotine patch was significantly more effective than placebo in highly dependent smokers. " 01/01/2020 - "The 4 mg nicotine lozenge provided a directionally significant improvement in smoking cessation rates compared with placebo in Chinese adult smokers with high nicotine dependence for the primary endpoint. " 08/01/2005 - "These effects have implications for the safety and efficacy of marihuana smokers who are self-medicating with the nicotine transdermal patch to manage their tobacco dependence." 01/01/2019 - "This trial aims to explore whether gradually transitioning to VLNC cigarettes plus nicotine patch or reducing CPD plus nicotine patch is more effective at decreasing nicotine dependence. " 12/01/2012 - "Twenty-four NC smokers and 20 smokers with SZ matched on nicotine addiction severity participated in a resting state fMRI study and were scanned during two separate sessions while receiving a placebo or nicotine patch, in a randomized, cross-over design. "
3.	Alcoholism (Alcohol Abuse) 04/01/2006 - "This study reports findings from an investigation of the efficacy of high-dose nicotine patch (NP) therapy for heavy smokers with a history of alcohol dependence. " 03/01/2004 - "This study reports findings from an investigation of the efficacy of high-dose nicotine patch (NP) therapy for heavy smokers with a past history of alcohol dependence. " 07/01/2005 - "In this pharmacological relapse prevention study for 195 smokers with alcohol dependence in sustained full remission, the primary aim was to determine the 7-day point prevalence smoking abstinence rate at the end of 8 weeks of nicotine patch therapy in doses projected to achieve 100% venous replacement. " 06/01/2003 - "Efficacy of nicotine patch in smokers with a history of alcoholism." 06/01/2003 - "One hundred fifteen smokers with a history of alcohol dependence (median of 5 years previously) were randomly assigned to either a 21-mg nicotine patch or placebo in a trial designed to be as similar as possible to a prior study that examined smokers with no history of alcoholism. "
4.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/01/2012 - "Secondary analysis of a randomized, placebo controlled smoking cessation trial assessing the efficacy of OROS-MPH taken in addition to nicotine patch among individuals with ADHD. " 12/01/2009 - "Fifty-two adults with ADHD (25 abstinent smokers and 27 nonsmokers) participated in a double-blind placebo controlled study with one nicotine patch condition and one placebo patch condition in counterbalanced order. " 12/01/2015 - "Stopping smoking yielded reductions in anxiety and depressed mood in smokers with ADHD treated with nicotine patch and counseling. " 02/01/2014 - "Thirty-two regular adult smokers with ADHD were randomized to receive LDX (n = 17) or placebo (n = 15) in addition to nicotine patch concurrent with a quit attempt. " 10/01/2011 - "Male and female adult smokers (ADHD-C = 167 and ADHD-IN = 87) were randomized to receive OROS-MPH or placebo as augmentation treatment to nicotine patch and counseling. "
5.	Weight Gain 12/01/2013 - "The results of this study indicate that nicotine patch may increase energy intake during treatment, and does not prevent post-cessation weight gain in postmenopausal smokers. " 04/01/2012 - "This study evaluated whether extended vs. standard duration treatment with nicotine patch helps those able to quit smoking to reduce cessation-induced weight gain and explored nicotine patch adherence as a mediator of treatment effects. " 01/01/1997 - "Hospital-based outpatients participating in a cognitive-behavioural group programme (2 hours/week over 5 weeks) were studied to evaluate the effectiveness of a 24-hour transdermal nicotine patch in assisting smokers to stop smoking when used as an adjunct to a cognitive-behavioural group programme, and to assess weight gain following cessation, using a randomized, double-blind, placebo-controlled trial with 12 months' follow-up. " 12/01/2013 - "High-dose nicotine patch therapy is associated with significant long-term attenuation of weight gain. " 12/01/2013 - "High-dose nicotine patch therapy was associated with significant weight gain attenuation among tobacco abstinence subjects at 3 months (p = .013) and 6 months (p = .018). "

Related Drugs and Biologics

1.	Nicotine
2.	Bupropion (Wellbutrin)
3.	Varenicline (Chantix)
4.	Cotinine
5.	Methylphenidate (Ritalin)
6.	Exenatide (Byetta)
7.	lorcaserin
8.	Smoke
9.	Rimonabant
10.	Glucagon-Like Peptide-1 Receptor

Related Therapies and Procedures

1.	Therapeutics
2.	Secondary Prevention
3.	Tobacco Use Cessation Devices
4.	Nebulizers and Vaporizers (Inhaler)
5.	Drug Therapy (Chemotherapy)